Cargando…

Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18

To evaluate the clinical predictive value of serum alpha-fetoprotein variants (AFP-L2, AFP-L3) in combination with maternal serum prenatal screening biomarkers in predicting fetal trisomy 21 and trisomy 18. We analyze the data of singleton pregnant women at 15–20(+6) weeks of 731,922 gravidas from O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yiming, Chen, Yijie, Ning, Wenwen, Zhang, Wen, Li, Liyao, Wang, Xiaoying, Yin, Yixuan, Zhang, Huimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365830/ https://www.ncbi.nlm.nih.gov/pubmed/35948592 http://dx.doi.org/10.1038/s41598-022-16807-x

Ejemplares similares

Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
por: Chen, Yiming, et al.
Publicado: (2023)

External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days
por: Chen, Yiming, et al.
Publicado: (2022)

A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy
por: Chen, Yiming, et al.
Publicado: (2021)

New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age
por: Chen, Yiming, et al.
Publicado: (2020)

Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case–control study
por: Chen, Yiming, et al.
Publicado: (2021)

Study on amniotic fluid metabolism in the second trimester of Trisomy 21
por: Liu, Xiaoting, et al.
Publicado: (2019)

Umbilical Cord Diameter at Early Second Trimester: Relation to Trisomy 21
por: Hantoushzadeh, Sedigheh, et al.
Publicado: (2019)

IONA test for first‐trimester detection of trisomies 21, 18 and 13
por: Poon, L. C., et al.
Publicado: (2015)

Application of an individualized nomogram in first‐trimester screening for trisomy 21
por: Sun, Y., et al.
Publicado: (2021)

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester
por: Xu, Danping, et al.
Publicado: (2021)

Fetuin A Concentration in the Second Trimester Amniotic Fluid of Fetuses with Trisomy 21 Appears to Be Lower: Phenotypic Considerations
por: Iliodromiti, S., et al.
Publicado: (2012)

Risk of Bronchopulmonary Dysplasia by Second Trimester Maternal Serum Levels of Alpha-fetoprotein, Human Chorionic Gonadotrophin, and Unconjugated Estriol
por: Jelliffe-Pawlowski, Laura L., et al.
Publicado: (2012)

An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019)

Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience
por: Sablok, Aanchal, et al.
Publicado: (2021)

Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free β-Subunit of Human Chorionic Gonadotropin, and Fetal Nuchal Translucency
por: Chen, Yiming, et al.
Publicado: (2022)

Variation of Ultrasound Findings in the First Trimester Examination of Recurrent Cases With Trisomy 21
por: Daniilidis, Aggelos, et al.
Publicado: (2015)

Explore the dynamic alternation of gene PLAC4 mRNA expression levels in maternal plasma in second trimester for nonivasive detection of trisomy 21
por: Yang, Lan, et al.
Publicado: (2015)

Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011)

Performance of non-invasive prenatal testing for trisomies 21 and 18 in twin pregnancies
por: Yang, Jiexia, et al.
Publicado: (2018)

Incorporation of dried blood alpha fetoprotein into traditional first trimester Down syndrome screening service
por: Carmichael, Jonathan, et al.
Publicado: (2015)

Employ ductus venous blood flow in the early detection of trisomy 21, trisomy 18, and trisomy 13: A meta-analysis
por: Ge, Yibing, et al.
Publicado: (2019)

Comparison of two immunoassay systems for hCGβ and PAPP-A in prenatal screening for trisomy 21, 18, and 13 in the first trimester
por: Engell, Anna Elise, et al.
Publicado: (2017)

Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
por: Weiner, Carl P., et al.
Publicado: (2022)

A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester
por: Luo, Wei, et al.
Publicado: (2023)

Predisposition to atherosclerosis in children and adults with trisomy 21: biochemical and metabolomic studies
por: Hetman, Marta, et al.
Publicado: (2023)

The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes
por: Öztürk, Hümeyra, et al.
Publicado: (2014)

Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection
por: Lin, Kongying, et al.
Publicado: (2021)

An Assessment of Selected Molecular and Biochemical Markers of the Folate Pathway as Potential Risk Factors for Fetal Trisomy 21 during the First Trimester of Pregnancy in the Polish Population
por: Ziółkowska, Katarzyna, et al.
Publicado: (2022)

Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer
por: Sun, Wenhui, et al.
Publicado: (2017)

Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
por: Lee, Da Eun, et al.
Publicado: (2013)

Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy
por: Sun, Li-Yue, et al.
Publicado: (2022)

Aberrant right subclavian artery as soft marker in the diagnosis of trisomy 21 during the first trimester of pregnancy
por: Martínez-Payo, Cristina, et al.
Publicado: (2021)

Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022)

Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma
por: Hu, Jian, et al.
Publicado: (2018)

Characterizations of Anti-Alpha-Fetoprotein-Conjugated Magnetic Nanoparticles Associated with Alpha-Fetoprotein for Biomedical Applications
por: Liao, Shu-Hsien, et al.
Publicado: (2017)

The trisomy 18 syndrome
por: Cereda, Anna, et al.
Publicado: (2012)

An unusual combination of trisomy 21 and partial trisomy 5q.
por: Kim, C. J., et al.
Publicado: (1992)

Cell‐free DNA testing in a trisomy 21 pregnancy with confined placental mosaicism for a cell line with trisomy for both chromosomes 18 and 21
por: Crooks, Kristy, et al.
Publicado: (2015)

The Feasibility Study of Non-Invasive Fetal Trisomy 18 and 21 Detection with Semiconductor Sequencing Platform
por: Jeon, Young Joo, et al.
Publicado: (2014)

Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta
por: Guibourdenche, Jean, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p5t6baf139u2ovu5pb2qs5d0g9